The Food and Drug Administration is gearing up to change how Covid vaccines are given out. Starting this fall, these vaccines will likely be reserved for older adults and those with specific health issues. This shift comes as officials question the benefit of extra doses for younger, healthier people who have already been vaccinated or had Covid.

The FDA's vaccine division chief and the agency's commissioner have raised concerns. They point out that the additional shots might not be as helpful for many young and middle-aged individuals. These people have either already been vaccinated or have had Covid. The officials argue that more studies are needed before approving the shots for this group.

Until now, everyone aged 6 months and older was recommended to get an annual Covid shot. But this might change. The FDA's scientific advisers are meeting to decide on the composition of the Covid vaccine for the fall. This decision could shape how the vaccine is distributed and who gets it.

The FDA plans to approve vaccines for high-risk individuals. At the same time, they want solid, reliable data on how well the vaccines work for those at low risk. This approach aims to ensure that the vaccines are both safe and effective for everyone.

The upcoming changes highlight the ongoing efforts to balance public health needs with scientific evidence. As the Covid-19 pandemic evolves, so do the strategies to combat it. The FDA's decisions will play a crucial role in shaping the future of Covid-19 vaccination efforts.

Who Gets the Fall Covid Shot?

Actions